Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Apolipoprotein L6 is a member of the apolipoprotein L gene family and is a cytoplasmic protein that may affect the movement of lipids within the cytoplasm or facilitate the binding of lipids to cellular organelles. It has proapoptotic properties and can induce mitochondria-mediated apoptosis, particularly in cancer cells, and has been associated with tumor aggressiveness and interactions with genes involved in the STAT signaling pathway and immune defense responses[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apolipoprotein L6 (APOL6).